Biotechnology Apellis Announces Submission of New Drug Application to the FDA for Pegcetacoplan for Geographic Atrophy June 1, 2022
Biotechnology Axsome Therapeutics Announces Late-Breaking Presentations of Positive Results of the EVOLVE Trial of AXS-05 in Major Depressive Disorder After Prior Treatment Failures at the American Society of Clinical Psychopharmacology (ASCP) 2022 Annual Meeting June 1, 2022
Biotechnology ChemoCentryx Announces Abstracts at June Rheumatology, Oncology and Nephrology Conferences May 31, 2022
Biotechnology Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Axsome Therapeutics, Inc. (AXSM) Investors of Class Action and Encourages Shareholders to Contact the Firm May 31, 2022
Biotechnology BioMarin Announces Durable Hemostatic Efficacy Maintained Over 6 years in Ongoing Phase 1/2 Study of Valoctocogene Roxaparvovec, Investigational Gene Therapy for Hemophilia A May 31, 2022
Health Denali Therapeutics and Biogen Announce Initiation of Phase 2b Study of LRRK2 Inhibitor in Parkinson’s Disease May 31, 2022
Search
Biotechnology
